Recursion Pharmaceuticals Stock Options

RXRX Stock  USD 5.84  0.32  5.80%   
Recursion Pharmaceuticals' latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 1.43 with a put-to-call open interest ratio of 1.0 over 38 outstanding agreements suggesting . The total put volume is at 410, with calls trading at the volume of 4.9 K. This yields a 0.08 put-to-call volume ratio.

Open Interest Against September 19th 2025 Option Contracts

Recursion Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Recursion Pharmaceuticals' lending market. For example, when Recursion Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Recursion Pharmaceuticals, he or she must hedge the risk by shorting Recursion Pharmaceuticals stock over its option's life.
The chart above shows Recursion Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Recursion Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Recursion Pharmaceuticals' option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Recursion Pharmaceuticals

Analyzing Recursion Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Recursion Pharmaceuticals regardless of its overall volatility. This is especially true when Recursion Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Recursion Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Recursion Pharmaceuticals' stock while costing only a fraction of its price.

Recursion Pharmaceuticals In The Money Call Balance

When Recursion Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Recursion Pharmaceuticals stock is said to be in the money. When it comes to buying Recursion Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Recursion Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Recursion Current Options Market Mood

Recursion Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Recursion Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Recursion Pharmaceuticals' options investors are not very successful. Recursion Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Recursion contract

Base on the Rule 16, the options market is currently suggesting that Recursion Pharmaceuticals will have an average daily up or down price movement of about 0.0894% per day over the life of the 2025-09-19 option contract. With Recursion Pharmaceuticals trading at USD 5.84, that is roughly USD 0.005219. If you think that the market is fully incorporating Recursion Pharmaceuticals' daily price movement you should consider buying Recursion Pharmaceuticals options at the current volatility level of 1.43%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Recursion Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Recursion calls. Remember, the seller must deliver Recursion Pharmaceuticals stock to the call owner when a call is exercised.

Recursion Pharmaceuticals Option Chain

When Recursion Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Recursion Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Recursion Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Recursion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Recursion. It also shows strike prices and maturity days for a Recursion Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
RXRX250919C0002000064520.00.0 - 0.250.05Out
Call
RXRX250919C000190006719.00.0 - 0.750.05Out
Call
RXRX250919C000180003018.00.0 - 0.750.07Out
Call
RXRX250919C000170004617.00.0 - 0.750.05Out
Call
RXRX250919C000160004116.00.0 - 0.750.75Out
Call
RXRX250919C0001500053515.00.05 - 0.150.12Out
Call
RXRX250919C000140009314.00.05 - 0.150.17Out
Call
RXRX250919C00013000114013.00.05 - 0.250.2Out
Call
RXRX250919C0001200054812.00.05 - 0.250.15Out
Call
RXRX250919C0001100028411.00.15 - 0.250.17Out
Call
RXRX250919C00010000357510.00.2 - 0.250.2Out
Call
RXRX250919C0000900041869.00.3 - 0.40.3Out
Call
RXRX250919C0000800078308.00.35 - 0.50.4Out
Call
RXRX250919C0000700058697.00.55 - 0.650.65Out
Call
RXRX250919C00006000121796.00.85 - 0.950.87Out
Call
RXRX250919C0000500090295.01.2 - 1.51.3In
Call
RXRX250919C0000400025024.01.05 - 2.151.9In
Call
RXRX250919C0000300011393.02.8 - 3.22.8In
Call
RXRX250919C000020001162.03.5 - 5.44.0In
Call
RXRX250919C00001000201.03.2 - 6.84.56In
 Put
RXRX250919P000200007320.013.8 - 14.313.8In
 Put
RXRX250919P00019000019.013.1 - 13.613.1In
 Put
RXRX250919P00018000018.011.8 - 12.611.8In
 Put
RXRX250919P00017000017.010.8 - 11.710.8In
 Put
RXRX250919P00016000016.09.8 - 10.79.8In
 Put
RXRX250919P00015000015.08.8 - 9.88.8In
 Put
RXRX250919P00014000014.07.8 - 8.67.8In
 Put
RXRX250919P00013000013.06.9 - 7.76.9In
 Put
RXRX250919P00012000112.06.0 - 6.46.0In
 Put
RXRX250919P0001100053811.04.9 - 5.65.82In
 Put
RXRX250919P0001000081310.04.0 - 4.74.8In
 Put
RXRX250919P000090001649.03.2 - 5.53.5In
 Put
RXRX250919P0000800013198.02.1 - 2.83.23In
 Put
RXRX250919P0000700011137.01.35 - 2.051.62In
 Put
RXRX250919P0000600081596.00.95 - 1.11.03In
 Put
RXRX250919P00005000340645.00.3 - 0.550.5Out
 Put
RXRX250919P0000400021014.00.1 - 0.30.18Out
 Put
RXRX250919P0000300017043.00.0 - 0.150.05Out

Recursion Total Stockholder Equity

Total Stockholder Equity

1.09 Billion

At this time, Recursion Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year.

Recursion Pharmaceuticals Corporate Management

Najat KhanChief OfficerProfile
Christopher GibsonCEO CoFounderProfile
Kevin LeggatVice AccountingProfile
Janelle GordonVice OperationsProfile
Shafique MDInterim OfficerProfile
Lina NilssonSenior PlatformProfile

Additional Tools for Recursion Stock Analysis

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.